Amdocs Limited (NASDAQ:DOX - Free Report) - Analysts at Zacks Research dropped their Q1 2025 EPS estimates for Amdocs in a report released on Tuesday, December 3rd. Zacks Research analyst R. Department now forecasts that the technology company will post earnings of $1.48 per share for the quarter, down from their previous estimate of $1.52. The consensus estimate for Amdocs' current full-year earnings is $6.19 per share. Zacks Research also issued estimates for Amdocs' Q4 2025 earnings at $1.65 EPS, FY2025 earnings at $6.21 EPS, Q2 2026 earnings at $1.66 EPS, Q4 2026 earnings at $1.75 EPS and FY2026 earnings at $6.72 EPS.
Several other research analysts also recently commented on the stock. Stifel Nicolaus started coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 target price on the stock. Oppenheimer upped their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 14th. Finally, Barclays lowered their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Amdocs currently has a consensus rating of "Moderate Buy" and a consensus target price of $101.20.
Check Out Our Latest Research Report on DOX
Amdocs Stock Performance
Shares of NASDAQ DOX traded down $0.41 during mid-day trading on Friday, reaching $86.64. 779,784 shares of the company's stock were exchanged, compared to its average volume of 760,323. The firm has a market capitalization of $10.18 billion, a price-to-earnings ratio of 20.43, a price-to-earnings-growth ratio of 1.46 and a beta of 0.72. Amdocs has a 52 week low of $74.41 and a 52 week high of $94.04. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.24. The firm has a 50-day moving average price of $88.12 and a two-hundred day moving average price of $84.25.
Amdocs Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.479 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.21%. Amdocs's dividend payout ratio (DPR) is presently 45.05%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in DOX. Private Trust Co. NA boosted its stake in Amdocs by 62.9% during the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after acquiring an additional 117 shares in the last quarter. Brooklyn Investment Group bought a new stake in shares of Amdocs in the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Amdocs in the 3rd quarter worth approximately $55,000. GAMMA Investing LLC increased its position in Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company's stock valued at $70,000 after buying an additional 428 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in Amdocs during the third quarter valued at $77,000. Hedge funds and other institutional investors own 92.02% of the company's stock.
About Amdocs
(
Get Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.